Shakun Malik

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Roy S. Herbst, David R. Gandara, Fred R. Hirsch et al. · Clinical Cancer Research · 2015 · 232 citations · Full text

Engineering, Biomarker-driven Protocol, Advanced Lung Disease +16

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

Eric C. Polley, Mark W. Kunkel, David M. Evans et al. · JNCI Journal of the National Cancer Institute · 2016 · 164 citations · Full text

Consensus Report of the 2015 Weinman International Conference on Mesothelioma

Michele Carbone, Shreya Kanodia, Ann Chao et al. · Journal of Thoracic Oncology · 2016 · 143 citations · Full text

Tumoral Pathology, Medicine, Surgical Pathology +5

U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non–Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive

Shakun Malik, V. Ellen Maher, Karen E. Bijwaard et al. · Clinical Cancer Research · 2014 · 138 citations

Alk-positive Nsclc, Pathology, Pharmacotherapy +16

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

Mary W. Redman, Vassiliki A. Papadimitrakopoulou, Katherine Minichiello et al. · The Lancet Oncology · 2020 · 114 citations · Full text

Prognostic Biomarkers, Medicine, Biomarker Target +10